Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
S-Adenosylmethionine decarboxylase (
AdoMetDC
) is a key enzyme in polyamine biosynthesis. We show that the plant
AdoMetDC
activity is subject to post-transcriptional control by polyamines. A highly conserved small upstream open reading frame (uORF) in the
AdoMetDC
mRNA 5' leader is responsible for translational repression of a downstream
beta-glucuronidase
reporter cistron in transgenic tobacco plants. Elimination of the small uORF from an
AdoMetDC
cDNA led to increased relative translational efficiency of the
AdoMetDC
proenzyme in transgenic plants. The resulting increased activity of
AdoMetDC
caused disruption to polyamine levels with depletion of putrescine, reduction of spermine levels, and a more than 400-fold increase in the level of decarboxylated S-adenosylmethionine. These changes were associated with severe growth and developmental defects. The high level of decarboxylated S-adenosylmethionine was not associated with any change in 5'-methylcytosine content in genomic DNA and S-adenosylmethionine levels were more or less normal, indicating a highly efficient system for maintenance of S-adenosylmethionine levels in plants. This work demonstrates that uORF-mediated translational control of
AdoMetDC
is essential for polyamine homeostasis and for normal growth and development.
...
PMID:Abrogation of upstream open reading frame-mediated translational control of a plant S-adenosylmethionine decarboxylase results in polyamine disruption and growth perturbations. 1220 86